Bloomberg predicts strong growth for the gene and cell therapy market
In an article from May 3, 2023, Bloomberg forecasts an annualized growth of 22.8 percent for
In an article from May 3, 2023, Bloomberg forecasts an annualized growth of 22.8 percent for
The National Institutes of Health (NIH) is a U.S. government agency with a proud history with
At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development
In early 2023, CombiGene and the Danish company Zyneyro initiated a collaboration to jointly develop the
It is just over four months since CombiGene began the collaboration on the pain program COZY
Alvar Grönberg is Senior Program Director at CombiGene. He has a PhD from Karolinska Institutet (KI)
Odd-Geir Berge has previously, among many other things, worked as a Senior Principal Scientist, Analgesia at
Zyneyro was founded by a group of researchers from the Department of Neuroscience at the University
Pain costs a lot in the form of daily human suffering. There are also great financial
Pain is a complex area, not least because there are several different types of pain, and